Floatz logo

Brexpiprazole

Manic Bipolar Affective Disorder

Otsuka Pharmaceutical Development & Commercialization, Inc.Small moleculePhase 3Dormant
BB
71/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
59/ 100
Competitive Position
95/ 100

Competitive context

6 Active assets in the Manic Bipolar Affective Disorder cohort.

Asset / SponsorPhaseRating
Risperidone
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Phase 4BBB
LITHIUM, ELEMENTAL
University of Cincinnati
Phase 4BBB
QUETIAPINE
University of Cincinnati
Phase 4BBB
LAMOTRIGINE
Medical University of South Carolina
Phase 4BB
Valproic Acid
Weill Medical College of Cornell University
Phase 4BB

View all 27 →

Same molecule, other indications

Brexpiprazole is also rated in:

depressive disorderActive
A
Indicative · Phase 4
82 / 100
View asset →
major depressive disorderActive
BBB
Indicative · Phase 4
75 / 100
View asset →
schizophreniaActive
BBB
Indicative · Phase 4
75 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →